MDIMP, a novel cardiac Ca(2+) channel blocker with atrial selectivity.
Santamaria-Herrera MA, Ríos-Pérez EB, de la Rosa JA, García-Castañeda M, Osornio-Garduño DS, Ramos-Mondragón R, Mancilla-Percino T, Avila G.
Santamaria-Herrera MA, et al. Among authors: avila g.
Eur J Pharmacol. 2016 Jun 15;781:218-28. doi: 10.1016/j.ejphar.2016.04.027. Epub 2016 Apr 21.
Eur J Pharmacol. 2016.
PMID: 27089820